Identification of novel hepatitis C virus-specific cytotoxic T lymphocyte epiotpe in NS3 region.

Hepatitis C virus (HCV)-specific cytotoxic T lymphocytes (CTL) are thought to be effective in limiting viral spread and in clearing virus during infection. Therefore, we attempted to establish HCV-specific CTL and identify novel HCV-specific CTL epitopes in a patient with acute hepatitis C by a novel screening method using recombinant vaccinia viruses (rVV) and synthetic peptides. CD8+CD45RA− T cells (memory T cells) were isolated from peripheral blood mononuclear cells (PBMC) of a patient with acute hepatitis C. HCV-specific CTL were cloned at limited dilutions and tested for HCV-specific CTL activity using a standard 51Cr release assay. CTL assay was performed using rVV expressing regions of HCV-J, and overlapping and truncated synthetic peptides from HCV-J. CTL recognizing the NS3 region were isolated by 51Cr release assay with rVV-HCV. Isolated CTL were restricted by HLA class I molecules B*5603. We confirmed that isolated CTL recognized 8-mer amino acids in the NS3 region of HCV-J by 51Cr release assay with overlapping and truncated synthetic peptides. In conclusion, we isolated HCV-specific CTL restricted by HLA-B*5603 and identified a novel HCV-specific CTL epitope (IPFYGKAI, amino acids 1373–1380) in the NS3 region. The identified HCV-specific CTL epitope might be useful for HCV therapy.